{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:48:52Z","timestamp":1794563332113,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,8,8]],"date-time":"2009-08-08T00:00:00Z","timestamp":1249689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00125-009-1455-z","type":"journal-article","created":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T03:15:36Z","timestamp":1249614936000},"page":"2101-2108","source":"Crossref","is-referenced-by-count":51,"title":["Circulating IL-18 and the risk of type 2 diabetes in women"],"prefix":"10.1007","volume":"52","author":[{"given":"M. F.","family":"Hivert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Shrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Meigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,8]]},"reference":[{"issue":"Suppl 3","key":"1455_CR1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ijo.0802496","volume":"27","author":"JS Yudkin","year":"2003","unstructured":"Yudkin JS (2003) Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 27(Suppl 3):S25\u2013S28","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1455_CR2","doi-asserted-by":"crossref","first-page":"447S","DOI":"10.1093\/ajcn\/83.2.447S","volume":"83","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA (2006) Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83:447S\u2013455S","journal-title":"Am J Clin Nutr"},{"key":"1455_CR3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/eje.1.01897","volume":"152","author":"T Skurk","year":"2005","unstructured":"Skurk T, Kolb H, Muller-Scholze S et al (2005) The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 152:863\u2013868","journal-title":"Eur J Endocrinol"},{"key":"1455_CR4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.metabol.2006.04.008","volume":"55","author":"JN Fain","year":"2006","unstructured":"Fain JN, Tichansky DS, Madan AK (2006) Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes. Metab Clin Exp 55:1113\u20131121","journal-title":"Metab Clin Exp"},{"key":"1455_CR5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2005.09.068","volume":"337","author":"IS Wood","year":"2005","unstructured":"Wood IS, Wang B, Jenkins JR et al (2005) The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. Biochem Biophys Res Commun 337:422\u2013429","journal-title":"Biochem Biophys Res Commun"},{"key":"1455_CR6","first-page":"E108","volume":"291","author":"R Krogh-Madsen","year":"2006","unstructured":"Krogh-Madsen R, Plomgaard P, Moller K et al (2006) Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol: Endocrinol Metab 291:E108\u2013E114","journal-title":"Am J Physiol: Endocrinol Metab"},{"key":"1455_CR7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.atherosclerosis.2005.11.013","volume":"188","author":"J Hulthe","year":"2006","unstructured":"Hulthe J, McPheat W, Samnegard A et al (2006) Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 188:450\u2013454","journal-title":"Atherosclerosis"},{"key":"1455_CR8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.ATV.0000163843.70369.12","volume":"25","author":"J Hung","year":"2005","unstructured":"Hung J, McQuillan BM, Chapman CM et al (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 25:1268\u20131273","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1455_CR9","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/oby.2006.248","volume":"14","author":"GP Guilder Van","year":"2006","unstructured":"Van Guilder GP, Hoetzer GL, Greiner JJ et al (2006) Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 14:2127\u20132131","journal-title":"Obesity"},{"key":"1455_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-07-0206","volume":"157","author":"JM Bruun","year":"2007","unstructured":"Bruun JM, Stallknecht B, Helge JW et al (2007) Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 157:465\u2013471","journal-title":"Eur J Endocrinol"},{"key":"1455_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2005.07.008","volume":"117","author":"CP Fischer","year":"2005","unstructured":"Fischer CP, Perstrup LB, Berntsen A et al (2005) Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 117:152\u2013160","journal-title":"Clin Immunol"},{"key":"1455_CR12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00125-005-1859-3","volume":"48","author":"M Bosch","year":"2005","unstructured":"Bosch M, Lopez-Bermejo A, Vendrell J, Musri M, Ricart W, Fernandez-Real JM (2005) Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass. Diabetologia 48:1841\u20131843","journal-title":"Diabetologia"},{"key":"1455_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.ijo.0803421","volume":"31","author":"M Straczkowski","year":"2007","unstructured":"Straczkowski M, Kowalska I, Nikolajuk A et al (2007) Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Int J Obes 31:221\u2013225","journal-title":"Int J Obes"},{"key":"1455_CR14","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.2337\/diacare.26.9.2622","volume":"26","author":"Y Aso","year":"2003","unstructured":"Aso Y, Okumura K, Takebayashi K et al (2003) Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 26:2622\u20132627","journal-title":"Diabetes Care"},{"key":"1455_CR15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/diacare.26.5.1647","volume":"26","author":"K Esposito","year":"2003","unstructured":"Esposito K, Nappo F, Giugliano F et al (2003) Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care 26:1647","journal-title":"Diabetes Care"},{"key":"1455_CR16","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.2337\/diabetes.54.10.2932","volume":"54","author":"B Thorand","year":"2005","unstructured":"Thorand B, Kolb H, Baumert J et al (2005) Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA\/KORA Augsburg Study, 1984\u20132002. Diabetes 54:2932\u20132938","journal-title":"Diabetes"},{"key":"1455_CR17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/78.6.1135","volume":"78","author":"K Esposito","year":"2003","unstructured":"Esposito K, Nappo F, Giugliano F et al (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78:1135\u20131140","journal-title":"Am J Clin Nutr"},{"key":"1455_CR18","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2008-0425","volume":"93","author":"MF Hivert","year":"2008","unstructured":"Hivert MF, Sullivan LM, Fox CS et al (2008) Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 93:3165\u20133172","journal-title":"J Clin Endocrinol Metab"},{"key":"1455_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-149-5-200809020-00005","volume":"149","author":"C Heidemann","year":"2008","unstructured":"Heidemann C, Sun Q, van Dam RM et al (2008) Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 149:307\u2013316","journal-title":"Ann Intern Med"},{"key":"1455_CR20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa010492","volume":"345","author":"FB Hu","year":"2001","unstructured":"Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790\u2013797","journal-title":"N Engl J Med"},{"key":"1455_CR21","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archinte.161.13.1581","volume":"161","author":"AE Field","year":"2001","unstructured":"Field AE, Coakley EH, Must A et al (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581\u20131586","journal-title":"Arch Intern Med"},{"key":"1455_CR22","doi-asserted-by":"crossref","first-page":"1220S","DOI":"10.1093\/ajcn\/65.4.1220S","volume":"65","author":"WC Willett","year":"1997","unstructured":"Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S\u20131231S","journal-title":"Am J Clin Nutr"},{"key":"1455_CR23","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.282.15.1433","volume":"282","author":"FB Hu","year":"1999","unstructured":"Hu FB, Sigal RJ, Rich-Edwards JW et al (1999) Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 282:1433\u20131439","journal-title":"JAMA"},{"key":"1455_CR24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE (2005) The nurses' health study: lifestyle and health among women. Nat Rev Cancer 5:388\u2013396","journal-title":"Nat Rev Cancer"},{"key":"1455_CR25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","volume":"53","author":"FB Hu","year":"2004","unstructured":"Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693\u2013700","journal-title":"Diabetes"},{"key":"1455_CR26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-5491.2005.01585.x","volume":"22","author":"MB Schulze","year":"2005","unstructured":"Schulze MB, Solomon CG, Rifai N et al (2005) Hyperproinsulinaemia and risk of type 2 diabetes mellitus in women. Diabet Med 22:1178\u20131184","journal-title":"Diabet Med"},{"key":"1455_CR27","volume-title":"Statistical analysis of epidemiologic data","author":"S Selvin","year":"1991","unstructured":"Selvin S (1991) Statistical analysis of epidemiologic data. Oxford University Press, New York"},{"key":"1455_CR28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","volume":"53","author":"FB Hu","year":"2004","unstructured":"Hu FB, Meigs JB, Li TY et al (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693\u2013700","journal-title":"Diabetes"},{"key":"1455_CR29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/oby.2007.528","volume":"15","author":"L Leick","year":"2007","unstructured":"Leick L, Lindegaard B, Stensvold D et al (2007) Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise. Obesity 15:356\u2013363","journal-title":"Obesity"},{"key":"1455_CR30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-2006-949122","volume":"38","author":"N Vilarrasa","year":"2006","unstructured":"Vilarrasa N, Vendrell J, Maravall J et al (2006) IL-18: relationship with anthropometry, body composition parameters, leptin and arterial hypertension. Horm Metab Res 38:507\u2013512","journal-title":"Horm Metab Res"},{"key":"1455_CR31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1055-9965.EPI-06-1089","volume":"16","author":"RC Kaplan","year":"2007","unstructured":"Kaplan RC, Ho GY, Xue X et al (2007) Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomark Prev 16:1291\u20131293","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1455_CR32","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1158\/1055-9965.EPI-07-0374","volume":"16","author":"SA Lee","year":"2007","unstructured":"Lee SA, Kallianpur A, Xiang YB et al (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomark Prev 16:2464\u20132470","journal-title":"Cancer Epidemiol Biomark Prev"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1455-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-009-1455-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-009-1455-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:47:13Z","timestamp":1558597633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-009-1455-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,8]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s00125-009-1455-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,8]]}}}